93 related articles for article (PubMed ID: 22156325)
1. Effect of obesity on declining beta cell function after diagnosis of type 2 diabetes: a possible link suggested by cross-sectional analysis.
Saisho Y; Tanaka K; Abe T; Shimada A; Kawai T; Itoh H
Endocr J; 2012; 59(3):187-95. PubMed ID: 22156325
[TBL] [Abstract][Full Text] [Related]
2. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
Saisho Y; Kou K; Tanaka K; Abe T; Kurosawa H; Shimada A; Meguro S; Kawai T; Itoh H
Endocr J; 2011; 58(4):315-22. PubMed ID: 21415555
[TBL] [Abstract][Full Text] [Related]
3. Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.
Wakasaki H; Shono T; Nakao R; Yamamoto S; Minaga T; Fukuda S; Matsumoto R; Ohoshi T; Naka K; Nanjo K
Intern Med; 2020; 59(18):2229-2235. PubMed ID: 32938850
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
5. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure.
Funakoshi S; Fujimoto S; Hamasaki A; Fujiwara H; Fujita Y; Ikeda K; Hamamoto Y; Hosokawa M; Seino Y; Inagaki N
Diabetes Res Clin Pract; 2008 Dec; 82(3):353-8. PubMed ID: 18950889
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional and Longitudinal Analyses of Factors Contributing to the Progressive Loss of the β-cell Function in Type 2 Diabetes.
Nakayama H; Kato T; Nakayama S; Kaku H; Muraishi K; Tokubuchi I; Hara K; Kato T; Wada N; Tsuruta M; Ohki T; Tanaka K; Mitsuzaki K; Tajiri Y; Yamada K
Intern Med; 2015; 54(16):1971-6. PubMed ID: 26278286
[TBL] [Abstract][Full Text] [Related]
7. Is type 2 diabetes a different disease in obese and nonobese patients?
Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P
Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730
[TBL] [Abstract][Full Text] [Related]
8. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
9. Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell function.
Torres-Rasgado E; Porchia LM; Ruiz-Vivanco G; Gonzalez-Mejia ME; Báez-Duarte BG; Pulido-Pérez P; Rivera A; Romero JR; Pérez-Fuentes R
Metab Syndr Relat Disord; 2015 Feb; 13(1):45-51. PubMed ID: 25423015
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum CPR to plasma glucose ratio with various indices of insulin secretion and diseases duration in type 2 diabetes.
Okuno Y; Sakaguchi K; Komada H; Hashimoto N; Hirota Y; Nakamura T; Ogawa W; Seino S
Kobe J Med Sci; 2013 Apr; 59(2):E44-53. PubMed ID: 23756662
[TBL] [Abstract][Full Text] [Related]
11. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C
Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540
[TBL] [Abstract][Full Text] [Related]
12. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: A cross-sectional study.
Liu J; Wang Y; Hu Y; Leng S; Wang G
J Diabetes Complications; 2016 Jul; 30(5):898-902. PubMed ID: 27012460
[TBL] [Abstract][Full Text] [Related]
13. Association between beta cell function and future glycemic control in patients with type 2 diabetes.
Saisho Y; Kou K; Tanaka K; Abe T; Shimada A; Kawai T; Itoh H
Endocr J; 2013; 60(4):517-23. PubMed ID: 23268927
[TBL] [Abstract][Full Text] [Related]
14. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
16. Serum bilirubin concentrations are positively associated with serum C-peptide levels in patients with Type 2 diabetes.
Chung JO; Cho DH; Chung DJ; Chung MY
Diabet Med; 2014 Nov; 31(11):1316-22. PubMed ID: 24910105
[TBL] [Abstract][Full Text] [Related]
17. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
18. Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
Tsuchiyama N; Takamura T; Ando H; Sakurai M; Shimizu A; Kato K; Kurita S; Kaneko S
Diabetes Care; 2007 Oct; 30(10):2583-7. PubMed ID: 17644622
[TBL] [Abstract][Full Text] [Related]
19. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
20. Postprandial metabolic responses to mixed versus liquid meal tests in healthy men and men with type 2 diabetes.
Brodovicz KG; Girman CJ; Simonis-Bik AM; Rijkelijkhuizen JM; Zelis M; Bunck MC; Mari A; Nijpels G; Eekhoff EM; Dekker JM
Diabetes Res Clin Pract; 2011 Dec; 94(3):449-55. PubMed ID: 21955958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
